Man Group
PBYI icon

Man Group’s Puma Biotechnology PBYI Stock Holding History

Man Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
47,375
+51
+0.1% +$329 ﹤0.01% 2210
2025
Q4 		$282K Buy
+47,324
New +$251K ﹤0.01% 2040
2025
Q2 		– Sell
-37,469
Closed -$111K – 2332
2025
Q1 		$111K Buy
+37,469
New +$117K ﹤0.01% 2101
2024
Q3 		– Sell
-117,665
Closed -$384K – 2145
2024
Q2 		$384K Sell
117,665
-94,017
-44% -$413K ﹤0.01% 1744
2024
Q1 		$1.12M Buy
211,682
+42,972
+25% +$231K ﹤0.01% 1503
2023
Q4 		$731K Buy
+168,710
New +$559K ﹤0.01% 1550
2023
Q1 		– Sell
-47,749
Closed -$180K – 1808
2022
Q4 		$202K Buy
47,749
+27,568
+137% +$95.1K ﹤0.01% 1768
2022
Q3 		$48K Buy
+20,181
New +$58.9K ﹤0.01% 1897
2022
Q2 		– Sell
-80,801
Closed -$201K – 1951
2022
Q1 		$233K Buy
80,801
+24,900
+45% +$64.4K ﹤0.01% 1874
2021
Q4 		$170K Buy
55,901
+33,701
+152% +$146K ﹤0.01% 1827
2021
Q3 		$156K Buy
+22,200
New +$166K ﹤0.01% 1786
2020
Q4 		– Sell
-34,134
Closed -$344K – 1912
2020
Q3 		$344K Sell
34,134
-6,200
-15% -$63.1K ﹤0.01% 1607
2020
Q2 		$421K Buy
40,334
+6,200
+18% +$64.2K ﹤0.01% 1491
2020
Q1 		$288K Sell
34,134
-16,433
-32% -$160K ﹤0.01% 1394
2019
Q4 		$442K Buy
+50,567
New +$419K ﹤0.01% 1608
2018
Q4 		– Sell
-7,860
Closed -$360K – 2067
2018
Q3 		$360K Buy
+7,860
New +$379K ﹤0.01% 1905

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Man Group's PBYI Position: Q1 2026 in Review

Man Group increased its Puma Biotechnology (PBYI) stake by 0.11% in Q1 2026, buying an estimated $329 and bringing the position to 47,375 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

Man Group first reported a position in PBYI in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.12M in Q1 2024. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Man Group held 47,375 shares of Puma Biotechnology worth $303K as of Q1 2026.
  • Man Group bought 51 Puma Biotechnology shares in Q1 2026, an estimated $329.
  • Puma Biotechnology made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2210 holding.
  • Man Group first reported a position in Puma Biotechnology in Q3 2018 and has held it in 16 quarters since.
  • Man Group's Puma Biotechnology position peaked at $1.12M in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.